SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-024734
Filing Date
2016-08-25
Accepted
2016-08-25 17:25:03
Documents
5
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q apvo-10q_20160630.htm 10-Q 1482801
2 EX-31.1 apvo-ex311_339.htm EX-31.1 17927
3 EX-31.2 apvo-ex312_340.htm EX-31.2 17978
4 EX-32.1 apvo-ex321_338.htm EX-32.1 9281
5 EX-32.2 apvo-ex322_337.htm EX-32.2 9288
  Complete submission text file 0001564590-16-024734.txt   1538283
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37746 | Film No.: 161852328
SIC: 2834 Pharmaceutical Preparations